TABD Innovation Conference Healthcare

8 May 2007 Berlin, Germany
This event is organised by the Trans Atlantic Business Dialogue (TABD) and is supported by the EU Commission and the US Department of Commerce. The underlying factors creating common challenges in Healthcare on both sides of the Atlantic range from demographics to pandemics or chronical diseases, to name but a few. This event aims to focus on the role and contribution that innovation and transatlantic innovation policies can play in addressing these challenges. The conference will bring together leaders from the private sector, academia and governments with a direct interest in the creation and use of innovation in Healthcare with a view to develop new thinking and show new cooperative ways on how to face and address these challenges. Concrete recommendations summarizing the results of these discussions should inform and guide future policy decision by the EU and US governments in this area.

TABD Mission Statement
For nearly 60 years, the transatlantic relationship has drawn its strength and durability from many different forms of partnership, notably in the political, economic and security areas.

The Transatlantic Business Dialogue (TABD) - which is the key interlocutor with government on the transatlantic economic relationship - has been renewed under fresh leadership and with a 30-strong business advisory board consisting of CEOs from companies across a range of business sectors in the EU and the US. This will bring a changed focus as well as another source of energy for the economic partnership in its own right, while also recognising the need to ensure that the economic, political and security relationship is rooted in an awareness of our common interests and values.

A strong transatlantic relationship enhances the capacity of the US and the EU to jointly influence global developments for the benefit of all countries, whatever their stage of development.

The TABD believes that neither side should take transatlantic economic ties for granted and that both should work harder to avoid the periodic regulatory and trade conflicts that trouble the relationship. But the economic agenda must look beyond conflict avoidance and management to develop joint responses to common global challenges. We shall play our part in pro-actively identifying those challenges and recommending appropriate responses through well-informed policy advice based on positions determined through the direct participation of our member companies chief executives.

For further information, please visit:

Most Popular Now

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...